Conexeu Sciences Closes $5 Million Private Placement

05:20 PM EDT, 10/15/2026 (MT Newswires) -- Conexeu Sciences Inc. (CNXU) said Thursday it closed a private placement of about $5 million, with participation from existing shareholders, management and directors, including Chief Executive Miles Harrison and Chief Commercial Officer David Bogart. The financing comprises 1.67 million units priced at $3 each, with each unit consisting of one common share and one warrant to purchase an additional share at $3 per share, exercisable for 24 months from issuance. Conexeu plans to use the proceeds for working capital and general corporate purposes, manufacturing scale-up, regulatory testing and preclinical work supporting a planned US Food and Drug Administration 510(k) submission for its Ten Minute Tissue wound care device in the first quarter of 2027. However, $250,000 in subscriptions from certain management members and directors is held in escrow pending shareholder approval.